Avani Yenamandra, PharmD, BCOP

home / authors / avani-yenamandra-pharmd-bcop

Articles

Hairy cell leukemia -- Image credit: Dr_Microbe | stock.adobe.com

Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia Treatment

Husna Rahim, PharmD, RPh;Sukeina Nasser, PharmD, RPh, CPh, PACS;Rezarta Lako, PharmD, BCPS;Richa Shah, PharmD, BCOP;Jessie Modlin, PharmD, BCOP;Avani Yenamandra, PharmD, BCOP;Kevin Pang, PharmD
February 24th 2025

BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.

Read More

Small cell lung cancer -- Image credit: Dr_Microbe | stock.adobe.com

Tarlatamab-dlle: A Beginning for Bispecific Therapies in Small Cell Lung Cancer

Avani Yenamandra, PharmD, BCOP
February 18th 2025

Second-line and later treatment options for small cell lung cancer are limited.

Read More

Blue ribbon for prostate cancer awareness -- Image credit: ActionGP | stock.adobe.com

A New Frontier: PARP Inhibitors Plus Antiandrogens in BRCA- or HRR-Mutated mCRPC

Avani Yenamandra, PharmD, BCOP
February 21st 2024

These combination therapies have demonstrated longer PFS with a tolerable AE profile.

Read More

Latest Updated Articles

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Milan, Italy - APRIL 10, 2021: CDC logo on laptop screen seen through an optical prism. Illustrative editorial image from CDC website.
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Image credit: catalin | stock.adobe.com
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
© 2025 MJH Life Sciences

All rights reserved.